Bicycle Therapeutics

Bicycle Therapeutics is a biotechnology company pioneering a new class of therapeutics based on its proprietary Bicycle® peptide technology platform. Headquartered in Cambridge, UK, with a subsidiary in Cambridge, Massachusetts, USA, Bicycle Therapeutics is developing a new class of drugs to treat oncology and other critical diseases using its proprietary Bicycle® platform. Bicycles® exhibit antibody-like affinity and precise targeting specificity.